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Abstract
Cancer cells consistently exhibit decreased stiffness; however, the onset and progression of this change have not been 
characterized. To study the development of cell stiffness changes, we evaluated the shear stiffness of populations of 
cells during transformation to a carcinogenic state. Bronchial epithelial cells were exposed to sodium arsenite to initiate 
early stages of transformation. Exposed cells were cultured in soft agar to further transformation and select for clonal 
populations exhibiting anchorage-independent growth. Shear stiffness of various cell populations in G1 was assessed using 
a novel non-invasive assay that applies shear stress with fluid flow and evaluates nanoscale deformation using quantitative 
phase imaging (QPI). Arsenic-treated cells exhibited reduced stiffness relative to control cells, while arsenic clonal lines, 
selected by growth in soft agar, were found to have reduced stiffness relative to control clonal lines, which were cultured in 
soft agar but did not receive arsenic treatment. The relative standard deviation (RSD) of the stiffness of Arsenic clones was 
reduced compared with control clones, as well as to the arsenic-exposed cell population. Cell stiffness at the population 
level exhibits potential to be a novel and sensitive framework for identifying the development of cancerous cells.
Introduction
Cancers exhibit widespread genetic diversity while simultane-
ously forming consistent biomechanical structures, tumors, 
which foster the development of diverse cell populations 
essential to tumor growth and metastasis. From a biomechani-
cal perspective, tumor development requires tightly regulated 
mechanical properties including the formation of a stiff extracel-
lular matrix (ECM) and deformable metastatic cell phenotypes 
(1). Such mechanical properties are increasingly recognized as 
robust indicators of cancer progression, where cellular deform-
ability and tumor stiffness can be used to determine malig-
nancy and assess metastatic potential (1–5). Numerous studies 
indicate that cancer cells from diverse developmental processes 
and tissue origins exhibit reduced cellular stiffness relative to 
non-cancer cells (2,3,6–8). Here, we explore the onset of cellu-
lar stiffness changes during various stages of arsenic-induced 
cellular transformation to evaluate whether subtle changes 
in cellular stiffness are detectable and to preliminarily assess 
whether such changes have potential as a biomarker of cell 
transformation.
To understand the relevance and complexity of cellular stiff-
ness as a biomarker of transformation, it is necessary to empha-
size the role of extracellular remodeling in cancer progression 
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and development of tumor subpopulations. During carcino-
genesis, extracellular deposition of collagen and vasculariza-
tion remodel the ECM, generating physical niches with distinct 
biomechanics (shear force upon cells, crowding) and chemi-
cal features (hypoxia, drivers of growth signaling). This spatial 
heterogeneity promotes the development of subpopulations, 
including metastatic populations, within the tumor through 
local selective pressures leading to the distribution of key cancer 
features across cooperating subpopulations (9–11). Additionally, 
ECM stiffening can promote a cellular process known as epithe-
lial to mesynchymal transition, during which cells lose features 
of differentiated epithelial cells and gain features of more motile 
mesynchymal cells, such as anchorage-independent growth 
(12,13). These cells are hypothesized to migrate out of the tumor 
via ‘collagen highways’, potentially making epithelial to mesyn-
chymal transition and cell deformability key aspects of metas-
tasis (12–14). Therefore, development of a stiffness biomarker 
presents an opportunity to view the process of carcinogenesis 
through a single property that may simultaneously reflect ECM 
remodeling and development of metastatic phenotypes. Given 
the interplay of ECM remodeling and tumor subpopulations, we 
focus upon cellular stiffness of a population of cells, rather than 
individual cells, when evaluating its potential as a biomarker.
The goal of our study is to assess whether cell stiffness can 
reflect the progression of cell transformation. We capture cells at 
early and late stages of transformation to assess whether subtle 
changes in cellular stiffness can be detected and whether early 
and late stages are distinguishable. To our knowledge, no studies 
have been conducted to evaluate cellular stiffness changes dur-
ing transformation nor in early stages of carcinogenesis. Thus, 
the cell culture procedure in this study is intended to serve as a 
proxy for in situ carcinogenesis and is used here to preliminarily 
gauge the utility of stiffness as a biomarker during early stages 
of transformation.
To begin the transformation process, cells were exposed to 
inorganic arsenic, a carcinogen with a broad mechanistic impact 
that is known to promote a range of different types of cancer 
including bladder, lung and prostate cancers (15–19). Arsenic 
exerts its intracellular influence through a wide range of molec-
ular interactions (17–20) that make it ideally suited to promote 
a proxy transformation process that is reflective of a true in situ 
process. After 4 weeks of arsenic exposure, we then selected for 
cells exhibiting anchorage-independent growth by seeding cells 
in soft agar. Anchorage-independent growth is important dur-
ing metastasis and is a key identifying feature of cancer cells 
and transformed cells (21,22). The shift in extracellular ten-
sion mediated by the agarose also advances the transforma-
tion process (4). Following development of these cell lines, we 
employed a novel method that utilizes fluid flow to apply shear 
stress and quantitative phase imaging (QPI) to assess nanoscale 
levels of cellular deformation in response to the applied pres-
sure (23). Unlike other methods that involve exogenous contact 
or application of dye, our method allows cells to maintain nor-
mal attachment and media conditions during measurement. 
Furthermore, this method allows for measurement of large sam-
ple sizes permitting detection of subtle differences in stiffness 
at the population level. The sensitivity of this method in com-
bination with the known phylogeny of cell populations permits 
analysis of stiffness changes during development rather than 
solely assessing it at the end point of the process.
Materials and methods
Cell culture protocol
Immortalized human bronchial epithelial cells (BEAS-2B#CRL-9609, ATCC, 
Manassas, VA) were cultured in Dulbecco’s Modified Eagle Medium (#11995-
065, Life Technologies) supplemented with 10% fetal bovine serum (Atlanta 
Biologicals) and 1% Penstrep (#15140-122, Life Technologies). Cells were 
maintained at 37°C with 5% CO2 and 100% humidity. All cells were a gift from 
Haobin Chen at New York University School of Medicine. Cells were cultured 
from mid-March 2015 to July 2015 for this experiment and were passaged 
every 4 days with media changes every 2 days using 0.05% trypsin (GIBCO). 
Human lung carcinoma cells (A549 #CRM-CRL-185, ATCC, Manassas, VA) were 
cultured in F-12K media (#21127022, Thermo Fischer Scientific) supplemented 
and cultured as above during July 2015. The BEAS-2B and A549 cell lines were 
authenticated in July 2015 and October 2017, respectively, by Genetica DNA 
Laboratories. BEAS-2B and A549 cells were authenticated via short tandem 
repeat profiling and each exhibited a 100% match to their reference profiles, 
BEAS-2B (ATCC CRL-9609) and A549 (ATCC CCL-185), respectively.
Cell populations
The phylogenetic relationships and the process for developing the cell popu-
lations used in this study are illustrated in Figure 1. All other graphs and fig-
ures are color coded to match this figure. The cellular populations are briefly 
introduced here. ‘Arsenic 4w’ and ‘Arsenic 12w’ are BEAS-2B cells exposed to 
arsenic for 4 and 12 weeks, respectively. ‘BEAS-2B’ is the control population 
cultured under the same conditions for 4 weeks but without arsenic exposure. 
Arsenic 4w cells were then seeded in soft agar and allowed to form colonies 
for an additional 4 weeks, after which individual colonies were extracted 
and re-established as monolayer clonal cell lines. Cells from these clonal 
cell lines were measured individually for stiffness and form the treatment 
group ‘Arsenic clones’. Correspondingly, BEAS-2B control cells went through 
the same soft agar process to form the control clones, ‘BEAS-2B clones’. The 
Arsenic 4w and BEAS-2B populations are the parental populations for their 
respective clonal populations, Arsenic clones and BEAS-2B clones.
Arsenic treatment
For the arsenic exposure, BEAS-2B cells were exposed to sodium meta ar-
senite (1 µM) (NaAsO2; S7400-100G; Sigma-Aldrich). Sodium meta arsenite 
was dissolved in Ultra Pure water (#10977-015, Life Technologies), filtered 
for sterilization with a 0.22 µm filter and added to media after every pas-
sage and media change. At 4 weeks, aliquots of BEAS-2B control cells and 
Arsenic 4w were frozen. Frozen cells were thawed and cultured for 10 days 
prior to measurement. Arsenic treatment was suspended 48  h prior to 
stiffness measurement for Arsenic 4w and Arsenic 12w.
Soft agar assay to clonal treatment groups
Cells were seeded at a density of 5 × 103 cells in the top layer of agarose 
media (0.35% agarose) over the bottom layer (0.5% agarose) in each well of 
a six-well plate, with no arsenic in media or agarose for either treatment 
group. Agarose plates were maintained in the incubator for an additional 
4 weeks with 200 µl of media added to the wells each week. After 4 weeks, 
colonies were counted, and numerous individual colonies were extracted 
from the agarose and re-established as separate monolayer cell lines 
as previously described (24). The treatment group referred to as Arsenic 
clones is comprised of cells from five arsenic clonal cell lines, and BEAS-2B 
clones is comprised of cells from four control clonal cell lines. Clonal cell 
lines were cultured separately for 4 weeks following the soft agar assay 
to permit observation of the natural range of stiffness values among 
the different clonal cell lines, which may vary due to fluctuations in the 
local microenvironment during development in agar. Since tumors are 
comprised of subpopulations that develop via local microenvironments 
(11,25–27), the aim was to approximate such variation by maintaining 
Abbreviations 
COM  center-of-mass
ECM  extracellular matrix
LR  likelihood ratio
ML  maximum likelihood
RSD  relative standard deviation
REML  restricted ML
QPI  quantitative phase imaging 
OPL optical path length
D
ow
nloaded from
 https://academ
ic.oup.com
/carcin/article-abstract/39/2/109/4563827 by D
TU
 Library - Technical Inform
ation C
enter of D
enm
ark user on 27 August 2019
A. Muñoz et al. | 111
clonal lines separately until the time of stiffness measurement. Stiffness 
measurements from the five arsenic clonal lines were then pooled to cre-
ate a proxy for a single tumor. Correspondingly, BEAS-2B clonal lines were 
also cultured separately and then pooled as the control.
Stiffness measurements
Shear stiffness measurements were obtained through a process that com-
bined high-resolution QPI with fluid induction of shear stress to record 
cellular displacement in response to the applied force. This novel meth-
odology that combines QPI with a flow cell was previously described in 
a proof-of-concept study by Eldridge et al. (23) and is briefly described 
below with additional description in Supplementary methods, available 
at Carcinogenesis Online.
Quantitative phase imaging
High-resolution imaging was performed using QPI, in a process that 
assesses phase delays generated by the object being measured. Phase 
delays are encoded in the incident light field and detected using 
interferometric techniques. QPI has previously been implemented 
to measure mechanical phenomena with nanometer optical path 
length (OPL) resolution, without the use of contrast agents (23). In QPI, 
light from a low coherence source is split into a reference beam and 
a sample beam. The sample beam passes through the object being 
measured, which imparts a phase delay according to the following 
relation:
φ pi λx y n x y d x y, , ( , ) /( )= D ( )2
Here, φ x y,( ) is the phase delay of the incident light field, λ is the wave-
length of the incident light wave, d(x,y) is the axial depth of the object and 
∆n(x,y) is the refractive index difference between the sample and the sur-
rounding media (23,28–30). From the phase information, the optical path 
length (OPL), defined as OPL(x,y) = ϕ(x,y)*λ/2π at each pixel within the cell, 
was recorded.
The QPI system used here employs an off-axis holographic technique 
for phase retrieval (Figure 2) (31). Light from a supercontinuum source 
(SuperK Compact, NKT Photonics) was spectrally filtered to produce an 
illumination of center wavelength λ=610 nm, and a bandwidth of ∆λ=1 nm, 
resulting in a coherence length of 214 µm.
Stiffness assessment
The day prior to cell stiffness measurement, cells were split and plated 
at a density of about 1000–3000 cells in 250 µL of complete media on 40 
mm round glass coverslips (Warner Instruments, CS-40R) inside a 60 mm 
dish to maintain sterility and humidity conditions. For measurement, 
complete media was gently removed from the glass coverslip using a 
pipette, and the coverslip was inserted into the closed chamber flow cell 
(Bioptechs, FCS3) mounted onto the optical setup as previously described 
(23). Cells were imaged for 2 s at zero shear stress, followed by 8 s of 
imaging during application of 8 dyne/cm2 (τs) shear stress by a syringe 
pump. Images captured during shear stress application collectively form 
a video of the cell (Supplementary Videos 1–2, available at Carcinogenesis 
Online). The media used to apply shear stress was Dulbecco’s modified 
eagle medium + 0.25% fetal bovine serum. All images were acquired at 
60 fps and an exposure of 16.7 ms using a fast CMOS camera (Fastcam 
SA4, Photron).
Approximately 30–50 cells were imaged per sample for a period of 
30–40 min. During imaging, cells were monitored for signs of intracellular 
stress (blebbing or detaching), and sample imaging was discontinued if 
present. Selection of cells for imaging was optimized for imaging condi-
tions by avoiding cells which were in contact with other cells, which may 
alter the response to shear stress (Supplementary Figure S1, L, available at 
Carcinogenesis Online). For the BEAS-2B-derived cell populations, selection 
during imaging was optimized to control for the substantial variability in 
morphology and surface area exhibited by the cells during the different 
phases of the cell cycle. Progression through the cell cycle is associated 
with shifts in cell shape, size and the arrangement of nuclear material 
(32), and cells in different stages of the cell cycle are correlated with cell 
cycle dependent stiffness magnitudes (33). Given the fluctuation of stiff-
ness over the cell cycle, we restricted sampling to the G1 phase to reduce 
the noise introduced by cell cycle variations. To implement this selection, 
we synchronized cells with the double thymidine block protocol to deter-
mine the morphology of the cells during the stages of the cell cycle (34). 
Cells in G1 exhibited visually identifiable teardrop (Supplementary Figure 
S1, Panel A, available at Carcinogenesis Online) and near-teardrop shapes 
(Supplementary Figure S1, Panels B–C, available at Carcinogenesis Online). 
Because the thymidine synchronization involves substantial stress on the 
cells, we chose to visually select cells during measurement in order to 
maintain normal culture conditions in the time leading up to stiffness 
measurement. Further details of the visual identification protocol are 
described in the supplement with associated OPL images (Supplementary 
Figure S1, Panels D–K, available at Carcinogenesis Online). Post-measurement 
checks on the visual selection protocol were implemented on image data 
prior to analysis to confirm that visual selection matched within treat-
ment group G1 mean cell surface area (Supplementary Methods, available 
at Carcinogenesis Online).
Figure 1. Treatment groups. BEAS-2B human bronchial epithelial cells were cul-
tured for 4 weeks with 1 μM sodium arsenite (Arsenic 4w) and in parallel without 
arsenic (BEAS-2B). The Arsenic 4w population and the BEAS-2B control population 
were then seeded in soft agar and allowed to form colonies. At the end of 4 weeks, 
individual colonies were extracted and re-established as monolayer clonal cell 
lines. Cells from the five arsenic clonal lines and four BEAS-2B control clonal lines 
were evaluated to assess cellular stiffness. During analysis, data from the clonal 
lines was pooled to form the treatment groups Arsenic clones and BEAS-2B clones. 
Simultaneous to the 8-week process to generate the clonal lines, Arsenic 4w was 
also continuously exposed to 1 μM sodium arsenite for an additional 8 weeks to 
form the Arsenic 12w population of cells. The Arsenic 4w and Arsenic 12w com-
prise the populations representative of early stage carcinogenesis, and the Arsenic 
clones comprise the population representative of later stage carcinogenesis.
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Calculation of effective shear stiffness parameter
The static image of each cell, obtained prior to fluid flow starting, was 
used as a reference to determine the center-of-mass (COM) of each cell. 
COM displacement was then determined by tracking COM movement 
relative to this initial location during the application of shear stress.
The net COM displacement was calculated from the series of images 
taken during the application of shear flow. The COM position was calcu-
lated using custom code (MATLAB R2013a) as previously described and 
was used to assess COM displacement during shear stress (23). This dis-
placement, | |( )

r tCOM , was tracked over time (t) and fit to the following 1D 
equivalent of the Kelvin–Voigt stiffness model (35):
| | ( )( )

r
F
k
t tkCOM
s
e s= - -1 η
Briefly, the force parameter (F) was obtained as the product of the cell 
surface area (As) and the shear stress of the fluid flow (τs). The mechanical 
application of media from a syringe pump provided a steady shear stress 
(τs) of 8 dyne/cm
2. The geometry of the flow cell ensured uni-directional 
passage of near laminar flow over the cells (23). Least-square fits were 
used to fit the COM displacement to the Kelvin–Voigt model in order to 
obtain the effective shear stiffness parameter (ks) and the damping par-
ameter (η).
Calculation of cellular orientation during 
measurement
Static images of each cell were used to obtain orientation during measure-
ment. Major and minor diameters were then calculated by fitting the cell 
perimeter to an ellipse and recording the axes of the fitted ellipse. From 
the orientation of these axes, the orientation of the cell with respect to 
the direction of flow (x-axis of the image) was determined and recorded.
Statistical analysis
Statistical analysis focused on ks, the shear stiffness in mN/m. Analysis 
was performed in R (36). Densities were estimated in R using the ‘density’ 
function. Stiffness values were transformed by the natural logarithm for 
analysis, as the non-transformed values exhibited skewed distributions 
within treatment groups. A linear normal model with log-transformed 
effective shear stiffness as the response variable was fit to the data from 
all five treatment groups (the five cellular populations). Treatment and 
cellular orientation during measurement were included as fixed effects, 
and within-group standard deviations were allowed to differ for the five 
treatments. Estimates of the fixed effects in the model along with 95% 
confidence intervals (CIs) were back-transformed to the original scale 
of measurement and are presented in Supplementary Table 1, available 
at Carcinogenesis Online. The fixed effects were estimated using maxi-
mum likelihood (ML), while the CIs are based on restricted ML (REML) 
estimates. REML estimates of the within-group standard deviations in 
the model, here denoted σˆ
g
 for treatment group g, were used to com-
pute model-based estimates of the relative standard deviation (RSD) of 
effective shear stiffness (on the original scale of measurement) using the 
formula exp( )ˆ .σ
g
2 1-  Note that an increment in standard deviation on 
the log scale corresponds to an increment of RSD on the original scale. 
Plots of orientation by treatment group indicated that observations within 
each treatment group were evenly spread across the possible values of ori-
entation, meaning that orientation does not distort the interpretation of 
summary statistics and density plots for the overall populations. However, 
due to the directionality of the shear flow established in the measurement 
setup, we opted to correct for cellular orientation in the model.
Figure 2. Optical setup and sample images. (A) Optical setup. Off-axis quantitative phase system for measuring mechanical displacements due to shear flow. The 
system employs a Mach-Zehnder holographic configuration by combining the sample light field with a uniform reference field, allowing for calculation of phase delay. 
The illumination wavelength of 610 nm had a bandwidth of 1 nm, serving to reduce coherence artifacts. OPL matching was implemented to maintain coherence across 
the field of view. (B) and (C) Sample OPL maps generated by the setup. OPL images are the product of cell depth and refractive index difference at a given pixel, enabling 
true quantitative analysis of cellular morphology.
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Each of the pairwise comparisons described in the following was car-
ried out as a separate test within the framework of the model described 
above. Hypotheses regarding fixed effects were tested using ML likeli-
hood ratio (LR) tests, while tests of hypotheses pertaining to variance 
parameters were carried out as REML LR tests. The effects of treatment 
on mean log-transformed effective shear stiffness were compared be-
tween the following groups: Arsenic 4w versus BEAS-2B; Arsenic 12w 
versus BEAS-2B; Arsenic clones versus BEAS-2B clones. On the original 
scale of measurement, these are interpreted as comparisons of me-
dian effective shear stiffness (for a fixed value of orientation). P-values 
from these three tests were Holm–Bonferroni adjusted in order to en-
sure a family-wise error rate of less than 5%. Furthermore, within-group 
standard deviations of log-transformed effective shear stiffness were 
compared between the following treatments: Arsenic 4w versus Arsenic 
clones; BEAS-2B versus BEAS-2B clones; Arsenic 4w versus BEAS-2B; 
Arsenic 12w versus BEAS-2B; Arsenic clones versus BEAS-2B clones. 
These are interpretable as comparisons of within-group RSD of effective 
shear stiffness on the original scale of measurement. P-values from 
these five tests were Holm–Bonferroni adjusted to ensure a family-wise 
error rate of less than 5%. Estimation of parameters in the linear normal 
model, computation of CIs and hypothesis testing were performed using 
functions from the R package nlme (37).
Results
Arsenic-treated cells compared with control 
BEAS-2B cells
Cells exposed to arsenic were probed for cellular shear stiff-
ness changes to assess whether changes could be detected at 
the start of cellular transformation. Summary statistics of raw 
data are presented in Table 1. Figure 3 contains plots illustrat-
ing cellular shear stiffness in Arsenic 4w (n = 53), Arsenic 12w 
(n = 73) and the corresponding control population, BEAS-2B (n = 
67). Figure 3A contains box plots of the raw data, while Figures 
3B and C contain probability density functions estimated from 
the raw data and from the log-transformed raw data, respect-
ively, for each treatment group. In these plots, subtle changes 
are evident in the arsenic-treated populations, which shift left 
and exhibit less variation relative to the BEAS-2B control popu-
lation. Estimates from the linear normal model for the treat-
ment effects of the three groups were back-transformed to 
the original scale and are presented in Figure 3D as estimated 
median cellular stiffness values (mN/m) for orientation zero, 
together with corresponding 95% CIs. The LR tests revealed a 
statistically significant decrease in the median effective shear 
stiffness of the Arsenic 4w population relative to the BEAS-2B 
population (P = 0.03) as well as for the Arsenic 12w relative to 
the BEAS-2B population (P < 0.001). The model-based estimates 
of RSD were 0.83 for Arsenic 4w, 0.79 for Arsenic 12w and 0.84 
for BEAS-2B. There was no significant difference in the RSD of 
effective shear stiffness for Arsenic 4w relative to BEAS-2B (P = 
1), nor for the Arsenic 12w relative to the BEAS-2B population 
(P = 1).
Arsenic clones compared with BEAS-2B clones
The Arsenic 4w population and BEAS-2B population were seeded 
in agar and allowed to form colonies for 4 weeks, after which 
individual colonies were extracted and re-established as mono-
layer cultures. Size of colonies was variable for both treatment 
groups. Colony counts from the soft agar assay are presented in 
Figure 4A. Control cells formed 3, 3 and 2 colonies per well, and 
the Arsenic 4w population formed 36, 52 and 35 per well. This 
factor 15 increase in the number of colonies formed in Arsenic 
4w over the background level indicates that the cells are trans-
formed, since high levels of anchorage-independent growth is a 
well-established marker of transformation (21,22,38). Summary 
statistics of cell stiffness in the treatment groups are presented 
in Table 1. Figure 4B contains boxplots of the raw data for cells 
from the individual Arsenic and BEAS-2B clonal lines. There are 
1–3 replicate samples from each cell line, and 14–35 cells in each 
sample, averaging 28 cells per sample. Figure 4C illustrates the 
pooled data, depicting one box for the Arsenic clones (n = 286) 
and one for the BEAS-2B clones (n = 224). Figures 4D and E show 
probability density functions estimated from the raw data and 
from the log-transformed raw data, respectively, for the two 
populations. The Arsenic clones clearly exhibit a higher dens-
ity of lowered stiffness values relative to the BEAS-2B clones. 
Estimates of treatment effects from the linear normal model, 
back-transformed to the original scale, are presented in Figure 
4F as estimated median cellular stiffness values (mN/m) for 
orientation zero, together with corresponding 95% CIs. The 
model-based estimate of RSD for the Arsenic clones was 0.55 
and for the BEAS-2B clones was 0.71. The LR tests showed a stat-
istically significant decrease in median effective shear stiffness 
for Arsenic clones relative to BEAS-2B clones (P < 0.001) as well 
as a significant decrease in the RSD of the effective stiffness of 
Arsenic clones relative to the BEAS-2B clones (P = 0.003).
Comparing cell populations before and after agar
To understand the impact of soft agar passage on the arsenic-
treated cells and the control cells, we statistically evaluated the 
difference in RSD of shear stiffness for a given population before 
(parental) and after agar (clonal). The Arsenic clones that passed 
through agar had a significantly reduced RSD compared with 
the Arsenic 4w parental population (P = 0.003), while BEAS-2B 
clones compared with the BEAS-2B parental population did not 
have a significantly reduced RSD (P = 0.54). All model-based RSD 
values are additionally listed in Supplementary Table 2, avail-
able at Carcinogenesis Online. To further illustrate the impact of 
agar, Figures 5A and B present the estimated probability density 
functions of the parental populations with their derived clonal 
populations based on the log-transformed data. For the Arsenic 
clones, the probability distribution after agar has reduced mean 
and standard deviation, reflecting the significant change in the 
population’s stiffness RSD.
Table I. Summary statistics for effective shear stiffness (mN/m)
Min (mN/m) Max (mN/m) Mean (mN/m) Median (mN/m) SD RSD n
Arsenic exposure
 Arsenic 4w 0.24 11.93 2.85 2.32 2.08 0.73 53
 Arsenic 12w 0.31 8.64 2.39 1.96 1.71 0.71 73
 BEAS-2B 0.60 15.20 4.09 2.65 3.38 0.83 67
Clones
 Arsenic clones 0.33 8.48 2.09 1.91 1.15 0.55 286
 BEAS-2B clones 0.51 15.47 3.18 2.50 2.31 0.72 224
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Comparison of shear stiffness across treatments
Overall median shear stiffness rankings for treatment popula-
tions from low to high are the following (based on back-trans-
formed model estimates for an orientation of zero degrees): 
Arsenic clones (1.84 mN/m); Arsenic 12w (1.90 mN/m); Arsenic 
4w (2.28 mN/m); BEAS-2B clones (2.58 mN/m) and BEAS-2B (3.05 
mN/m). Control populations (BEAS-2B and BEAS-2B clones) 
exhibited the highest maximum values and the widest distri-
butions, while the Arsenic clones had the narrowest distribu-
tions. For comparison of our data to a lung cancer cell line, we 
measured the stiffness of A549 cells (n = 60). Empirical median 
and mean stiffness were 2.22 mN/m and 2.42 mN/m, respec-
tively, with an RSD of 0.47. A549 cells exhibit stiffness that fits 
well within the arsenic populations, with empirical median and 
mean values lower than those of Arsenic 4w and higher than 
those of Arsenic 12w and Arsenic clones. Figure 5C presents the 
boxplots of raw stiffness data for the five treatment populations. 
In summary, our data reveal that arsenic-treated populations 
exhibit reduced cellular stiffness, and that passage through soft 
agar further decreases stiffness, resulting in the lowest stiffness 
values and variation for the arsenic clonal population.
Discussion
In studying the onset and progression of cellular stiffness 
changes during transformation, we have observed that a sub-
tle evolution of stiffness properties is detectable. The arse-
nic-treated populations, Arsenic 4w and Arsenic 12w, had 
statistically significant reductions in cellular stiffness compared 
with the control population. The stiffness reduction was further 
magnified when Arsenic 4w cells were passaged through soft 
agar, which resulted in an additional reduction of stiffness in 
the Arsenic clones and the smallest RSD of any of the arsenic 
and control populations. The Arsenic clones were, therefore, 
delineated by the magnitude of median stiffness and also by the 
significantly reduced RSD, suggesting the potential value of cell 
stiffness for tracking the depth of transformation progression.
As discussed in the introduction, the cell culture system 
used to produce the various cell populations is intended to serve 
as a proxy for in situ carcinogenesis. Understanding how arse-
nic-induced transformation is a relevant proxy for wider cancer 
processes requires consideration of various topics. First, since 
many cancerous processes are promoted or advanced by envi-
ronmental toxicants, it is important to note that the dose uti-
lized in this experiment, which was 1 μM (130 ppb or 130 μg/L), 
is environmentally relevant for individuals exposed to arsenic 
contaminated drinking water (39,40). Contaminated water in 
regions such as Bangladesh has arsenic doses ranging up to 1000 
ppb, placing 130 ppb well within the mid-range exposure level 
(39,41). Additionally, since we utilize low doses of arsenic that 
have low cytotoxicity, we have a prolonged exposure period dur-
ing which arsenic-induced genetic and epigenetic changes can 
accumulate, again mirroring carcinogenesis in a wider sense 
(17–19). Apart from these features, recent studies indicate that 
arsenic may enrich stem cells and selectively transform them 
(42,43). Evaluation of arsenic’s ability to enrich stem cells was 
Figure 3. Plots of shear stiffness data for arsenic-exposed cell populations and the corresponding BEAS-2B control population. (A) Boxplots of raw data. (B) Estimated 
probability density computed from the raw data (C) Estimated probability density computed from log-transformed data. (D) Estimates of median cellular shear stiffness 
(mN/m) for orientation zero with 95% CIs. P-values are for the pairwise comparisons Arsenic 4w and BEAS-2B, and Arsenic 12w and BEAS-2B. Statistical significance 
of P-values is indicated by, *P ≤ 0.05 and ***P ≤ 0.001.
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conducted in prostate cell lines with a five times higher dose 
of arsenic, making it unclear to what extent this phenomenon 
occurs in our study since the higher dose is more cytotoxic. 
However, given the strong evidence, it is possible that stem 
cells are also selectively enriched here, and that cancer stem 
cells are part of the arsenic-treated populations, which would 
further justify their status as a viable proxy for true carcino-
genic cell populations. Thus, arsenic’s role in this experiment is 
manifold, and its capacity to promote numerous effects mirrors 
the wide range of deregulated processes often present during 
carcinogenesis.
The Arsenic clones, which received both the intracellular 
(arsenic) and extracellular (agar passage) modifications, exhib-
ited the greatest decrease in cellular stiffness of any of the 
populations (Figure 5C). This significant reduction was accom-
panied by a reduced RSD and thus a narrowed distribution 
when Arsenic clones were compared with control clones (Figure 
4). Modifications of the extracellular environment are known 
to mediate intracellular changes through mechanotransduc-
tion, a process that is increasingly recognized for its ability to 
advance carcinogenesis where changes in the tensile properties 
of the environment are translated to changes in mechanical 
integrity and pre-stress of the cell (13,44–46). Thus, we infer that 
the soft agar not only selected for clones exhibiting anchorage-
independent growth but in doing so, advanced the process of 
transformation. To further contextualize the signal observed in 
the clones, it is instructive to compare the arsenic clonal pop-
ulation results with fully developed cancer cells to show that 
Arsenic clones are representative of later stage cancer cells. As 
mentioned previously, we measured A549 cells, a lung cancer 
cell line, and found these cancer cells to exhibit stiffness values 
within the range of the arsenic treated and transformed cells, 
corroborating that the arsenic-treated populations are in various 
stages of transformation. Further, the empirical RSD of the A549 
cell line was the lowest of all the populations and consistent 
with the notion that stiffness RSD is reduced as carcinogenesis 
advances. The reduced stiffness and RSD observed in the Arsenic 
clones and A549 cells are also consistent with numerous stud-
ies that have evaluated the stiffness of cancer cells from various 
lineages using a variety of methods (2,47,48). For example, AFM 
studies conducted on cell lines have found that breast cancer 
MCF-7 cells had lower elastic modulus relative to benign breast 
Figure 4. Plots of shear stiffness data for arsenic clonal population compared with BEAS-2B clones. (A) Colony count for triplicate soft agar assays of Arsenic 4w and 
BEAS-2B populations. BEAS-2B formed 3, 3 and 2 colonies per well, while the Arsenic 4w population formed 36, 52 and 35 colonies per well. Five Arsenic 4w clones 
became the arsenic clonal cell lines comprising Arsenic clones. Four BEAS-2B clones became the BEAS-2B clonal cell lines comprising the BEAS-2B clones. (B) Boxplots 
of raw data for individual clonal lines. Labels indicate treatment group, clonal line number and replicate sample number. Each replicate sample resulted in individual 
stiffness measurements for 14–35 cells, with sample sizes averaging 28 cells. Arsenic clones 1–5 and BEAS-2B clones 1–4 form the two treatment groups depicted in (C) 
Boxplots of raw data for pooled Arsenic clones (n = 286) and BEAS-2B clones (n = 224). (D) Estimated probability densities computed from the raw data. (E) Estimated 
probability densities computed from log-transformed data. (F) Estimates of median cellular shear stiffness (mN/m) for orientation zero with 95% CIs. Statistical signifi-
cance of P-values is indicated by, ***P ≤ 0.001.
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MCF-10A cells (7), and that malignant prostate cancer cell lines 
PC-3 and LNCAp had significantly lower elastic modulus than 
benign prostate bpH cells (8). Studies using microfluidic opti-
cal stretchers confirm these deformability findings in numerous 
breast cancer cell lines, where grading of malignancy is possible 
based on stiffness such that metastatic cells deform more than 
non-metastatic cancer cells (49). Further, others have observed 
that there was a three-fold reduction in the standard deviation 
of the stiffness property in metastatic cells (2). Thus, the overall 
pattern confirms that the reduced stiffness and reduced RSD of 
the Arsenic clones seen here is consistent with the properties of 
established cancer cell lines and cancer cells harvested in situ.
In Figures 5A and B, the differences between the pre- and 
post-agar populations are compared. This figure illustrates the 
biomechanical impact of passage through agar and indicates 
that the passage resulted in a different distribution of responses 
depending on whether arsenic treatment occurred prior to agar. 
To statistically evaluate the impact of agar on cells, we tested 
whether the RSDs of cell stiffness for the pre- and post-agar 
populations were different and found that only the arsenic-
treated population exhibited a significant reduction in RSD after 
agar. This observation is relevant because it provides a basis for 
connecting early and late stage populations through the stiff-
ness signal and suggests that either the lowered stiffness of 
Arsenic 4w or intracellular changes induced by arsenic were a 
pre-condition for the reduced RSD. Recall, that the A549 lung 
cancer cells had the lowest RSD of any population, supporting 
the notion that RSD reflects depth of transformation. Taken 
together, these findings indicate that stiffness is a rich signal 
capable of detecting subtle shifts in cellular transformation. 
Further development toward a biomarker would require study 
of this process in situ and determination of the appropriate ref-
erence distribution, which may vary with respect to factors such 
as cell type and age.
Based on the findings of our study, which serves as a proxy 
for carcinogenesis in situ, cellular stiffness shows promise for 
future development as an indicator of cell transformation pro-
gression. In early stages of transformation, we observe that 
reduction of median stiffness values occurs after 1 month of 
arsenic exposure and increases as exposure progresses. Later 
stages of this process, represented by the Arsenic clones, exhibit 
additional reduction of stiffness accompanied by a reduction in 
the RSD of the population. Stiffness and RSD of the A549 cells 
support that our findings are consistent with those of a true 
cancer cell line. Continued development of cell stiffness as a 
biomarker that leverages the sensitivity of this property at the 
cell population level may have great value for cancer prevention, 
screening and diagnostic procedures.
Figure 5. Graphical Summary. Estimated probability densities computed from the log-transformed measurements of cell stiffness (mN/m) to compare pre- and post-
agar populations (A) for control BEAS-2B and BEAS-2B clones and (B) for Arsenic 4w and Arsenic clones. (C) Boxplots of raw cell stiffness data (mN/m) for all treatment 
groups.
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